Polymer films

US10227463B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10227463-B2
Application numberUS-201615199633-A
CountryUS
Kind codeB2
Filing dateJun 30, 2016
Priority dateSep 19, 2013
Publication dateMar 12, 2019
Grant dateMar 12, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Biodegradable, cross-linked polymer films and methods of making the same are described. The polymer films can be used for preventing adhesions following surgery and/or delivering therapeutic agents.

First claim

Opening claim text (preview).

We claim: 1. A polymer film comprising: at least one monomer including at least one functional group selected from acrylate, acrylamide, methacrylate, or methacrylamide; and at least one glycidyl, carbonate, carbamate, TMP gly ester, thioester, or jeffamine glycidyl amine crosslinker including at least one linkage susceptible to degradation through hydrolysis or enzymatic action. 2. The polymer film of claim 1 , wherein the at least one monomer includes an ionizable functional group. 3. The polymer film of claim 2 , wherein the ionizable functional group is basic or acidic. 4. The polymer film of claim 1 , wherein the at least one glycidyl, carbonate, carbamate, TMP gly ester, thioester, or jeffamine glycidyl amine crosslinker includes at least two functional groups. 5. The polymer film of claim 1 , wherein the at least one linkage is an ester, a thioester, a carbonate, a carbamate, or a combination thereof. 6. The polymer film of claim 1 , including a second crosslinker including a second linkage selected from an ester, a thioester, a carbonate, a carbamate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenases, a peptide cleavable by matrix elastases, and a peptide cleavable by matrix cathepsins. 7. The polymer film of claim 1 , wherein the polymer film is substantially degraded within about 6 months of implantation. 8. The polymer film of claim 1 , wherein the polymer film is substantially degraded within about 1 month of implantation. 9. The polymer film of claim 1 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bis-glycidyl amino alcohol. 10. A polymer film comprising: at least one monomer; and at least one crosslinker selected from bis-glycidyl amino alcohol, bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate, wherein a, b, c, d, e, and f are each independently 1-20. 11. The polymer film of claim 10 , wherein the at least one monomer includes at least one functional group selected from acrylate, acrylamide, methacrylate, or methacrylamide. 12. The polymer film of claim 10 , wherein the at least one monomer includes an ionizable functional group. 13. The polymer film of claim 12 , wherein the ionizable functional group is basic. 14. The polymer film of claim 12 , wherein the ionizable functional group is acidic. 15. The polymer film of claim 10 , including a second crosslinker including a linkage selected from an ester, a thioester, a carbonate, a carbamate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenases, a peptide cleavable by matrix elastases, and a peptide cleavable by matrix cathepsins. 16. The polymer film of claim 10 , wherein the polymer film is substantially degraded within about 6 months of implantation. 17. The polymer film of claim 10 , wherein the polymer film is substantially degraded within about 1 month of implantation. 18. The polymer film of claim 10 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bis-glycidyl amino alcohol. 19. The polymer film of claim 10 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate.

Assignees

Inventors

Classifications

  • Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone} · CPC title

  • Materials at least partially resorbable by the body · CPC title

  • Monomers containing two or more (meth)acrylamide groups, e.g. N,N'-methylenebisacrylamide · CPC title

  • Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title

  • Acrylamide; Methacrylamide · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10227463B2 cover?
Biodegradable, cross-linked polymer films and methods of making the same are described. The polymer films can be used for preventing adhesions following surgery and/or delivering therapeutic agents.
Who is the assignee on this patent?
Microvention Inc
What technology area does this patent fall under?
Primary CPC classification C08F120/56. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 9 related publications on this page (citations in our corpus or others sharing the same primary CPC).